X Zell

X-ZELL is a Thailand-based medical technology company (Y Combinator W15) building a multiplex cytopathology product ecosystem that combines cryofixation, immunostaining, and digital imaging to turn limited cytology specimens into data-rich diagnostic workflows. Its Cryosuite platform pairs a Cryofixator and Cryostainer for specimen processing and automated staining, alongside Cryophore multiplex antibody panels for pleural fluid, ascitic fluid, and tumor-origin analysis, validated conjugated antibodies, and ISO 13485-certified reagent and OEM manufacturing. Founded by physician-scientist Sebastian Punyaratabandhu Bhakdi, the company originated in rare-cell detection (Circulating Endothelial Cells). It is a hardware, reagent, and laboratory-instrument business and publishes no public API, developer platform, SDKs, or machine-readable API specifications at this time.

X Zell is profiled on the APIs.io network. Tagged areas include Company, Medical Technology, Cytopathology, Diagnostics, and Laboratory Instruments.

X Zell’s developer surface includes support and 5 more developer resources.

8.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyMedical TechnologyCytopathologyDiagnosticsLaboratory InstrumentsLife SciencesReagentsHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 8.9/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.8 / 17
Access Clarity 3.6 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.5 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/x-zell: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 3

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: x-zell
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/x-zell.png
name: X Zell
description: X-ZELL is a Thailand-based medical technology company (Y Combinator W15) building a multiplex cytopathology product
  ecosystem that combines cryofixation, immunostaining, and digital imaging to turn limited cytology specimens into data-rich
  diagnostic workflows. Its Cryosuite platform pairs a Cryofixator and Cryostainer for specimen processing and automated staining,
  alongside Cryophore multiplex antibody panels for pleural fluid, ascitic fluid, and tumor-origin analysis, validated conjugated
  antibodies, and ISO 13485-certified reagent and OEM manufacturing. Founded by physician-scientist Sebastian Punyaratabandhu
  Bhakdi, the company originated in rare-cell detection (Circulating Endothelial Cells). It is a hardware, reagent, and laboratory-instrument
  business and publishes no public API, developer platform, SDKs, or machine-readable API specifications at this time.
url: https://raw.githubusercontent.com/api-evangelist/x-zell/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- y-combinator
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Medical Technology
- Cytopathology
- Diagnostics
- Laboratory Instruments
- Life Sciences
- Reagents
- Healthcare
common:
- type: Website
  url: https://www.x-zell.com
- type: TermsOfService
  url: https://www.x-zell.com/terms
- type: PrivacyPolicy
  url: https://www.x-zell.com/privacy
- type: Support
  url: https://www.x-zell.com/contact
- type: LinkedIn
  url: https://www.linkedin.com/company/xzell
- type: Twitter
  url: https://x.com/XZELLInc
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: nochange
  artifacts_added: 0
  pass: local-v1